Publications:

---

Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway.

Nature Communications

González, Lorena L; Díaz, Lucía L; Pous, Joan J; Baginski, Blazej B; Duran-Corbera, Anna A; Scarpa, Margherita M; Brun-Heath, Isabelle I; Igea, Ana A; Martin-Malpartida, Pau P; Ruiz, Lidia L; Pallara, Chiara C; Esguerra, Mauricio M; Colizzi, Francesco F; Mayor-Ruiz, Cristina C; Biondi, Ricardo M RM; Soliva, Robert R; Macias, Maria J MJ; Orozco, Modesto M; Nebreda, Angel R AR

Publication Date: 2023-06-12

Variant appearance in text: FGFR3: G697C

PubMed Link: 37308482

Variant Present in the following documents:

• 41467_2023_39051_MOESM3_ESM.xlsx, sheet 5

View BVdb publication page

---

Assessing variants of uncertain significance implicated in hearing loss using a comprehensive deafness proteome.

Human Genetics

Tollefson, Mallory R MR; Gogal, Rose A RA; Weaver, A Monique AM; Schaefer, Amanda M AM; Marini, Robert J RJ; Azaiez, Hela H; Kolbe, Diana L DL; Wang, Donghong D; Weaver, Amy E AE; Casavant, Thomas L TL; Braun, Terry A TA; Smith, Richard J H RJH; Schnieders, Michael J MJ

Publication Date: 2023-04-22

Variant appearance in text: FGFR3: 2089G>T; Gly697Cys

PubMed Link: 37086329

Variant Present in the following documents:

• 439_2023_2559_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Discovery of an In Vivo Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones.

Journal Of Medicinal Chemistry

Harnden, Alice C AC; Davis, Owen A OA; Box, Gary M GM; Hayes, Angela A; Johnson, Louise D LD; Henley, Alan T AT; de Haven Brandon, Alexis K AK; Valenti, Melanie M; Cheung, Kwai-Ming J KJ; Brennan, Alfie A; Huckvale, Rosemary R; Pierrat, Olivier A OA; Talbot, Rachel R; Bright, Michael D MD; Akpinar, Hafize Aysin HA; Miller, Daniel S J DSJ; Tarantino, Dalia D; Gowan, Sharon S; de Klerk, Selby S; McAndrew, Peter Craig PC; Le Bihan, Yann-Vaï YV; Meniconi, Mirco M; Burke, Rosemary R; Kirkin, Vladimir V; van Montfort, Rob L M RLM; Raynaud, Florence I FI; Rossanese, Olivia W OW; Bellenie, Benjamin R BR; Hoelder, Swen S

Publication Date: 2023-04-07

Variant appearance in text: FGFR3: G697C

PubMed Link: 37026591

Variant Present in the following documents:

• jm3c00155_si_002.xlsx, sheet 2

View BVdb publication page

---

Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum.

Acs Chemical Biology

Tredup, Claudia C; Ndreshkjana, Benardina B; Schneider, Natalie S NS; Tjaden, Amelie A; Kemas, Aurino M AM; Youhanna, Sonia S; Lauschke, Volker M VM; Berger, Benedict-Tilman BT; Krämer, Andreas A; Berger, Lena M LM; Röhm, Sandra S; Knapp, Stefan S; Farin, Henner F HF; Müller, Susanne S

Publication Date: 2023-03-21

Variant appearance in text: FGFR3: G697C

PubMed Link: 36944371

Variant Present in the following documents:

• cb2c00877_si_004.xlsx, sheet 1

View BVdb publication page

---

Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton's tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics.

Plos One

Kozaki, Ryohei R; Yasuhiro, Tomoko T; Kato, Hikaru H; Murai, Jun J; Hotta, Shingo S; Ariza, Yuko Y; Sakai, Shunsuke S; Fujikawa, Ryu R; Yoshida, Takao T

Publication Date: 2023

Variant appearance in text: FGFR3: G697C

PubMed Link: 36897912

Variant Present in the following documents:

• pone.0282166.s009.xlsx, sheet 1

View BVdb publication page

---

VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia.

Leukemia

Sher, Steven S; Whipp, Ethan E; Walker, Janek J; Zhang, Pu P; Beaver, Larry L; Williams, Katie K; Orwick, Shelley S; Ravikrishnan, Janani J; Walker, Brandi B; Perry, Elizabeth E; Gregory, Charles C; Purcell, Matthew M; Pan, Alexander A; Yan, Pearlly P; Alinari, Lapo L; Johnson, Amy J AJ; Frigault, Melanie M MM; Greer, Joy M JM; Hamdy, Ahmed A; Izumi, Raquel R; Mo, Xiaokui X; Sampath, Deepa D; Woyach, Jennifer J; Blachly, James J; Byrd, John C JC; Lapalombella, Rosa R

Publication Date: 2022-11-14

Variant appearance in text: FGFR3: G697C

PubMed Link: 36376377

Variant Present in the following documents:

• 41375_2022_1758_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety.

Journal Of Medicinal Chemistry

Pandrala, Mallesh M; Bruyneel, Arne Antoon N AAN; Hnatiuk, Anna P AP; Mercola, Mark M; Malhotra, Sanjay V SV

Publication Date: 2022-08-25

Variant appearance in text: FGFR3: G697C

PubMed Link: 35944901

Variant Present in the following documents:

• jm1c01853_si_003.xlsx, sheet 1

View BVdb publication page

---

Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma.

Frontiers In Oncology

Yin, Xiang-Qian XQ; Yin, Xue-Hui XH; Yu, Ya-Qin YQ; Xu, Lang L; Zhang, Mao M

Publication Date: 2022

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 35936718

Variant Present in the following documents:

• Table_4.xlsx, sheet 2

View BVdb publication page

---

Reengineering Ponatinib to Minimize Cardiovascular Toxicity.

Cancer Research

Hnatiuk, Anna P AP; Bruyneel, Arne A N AAN; Tailor, Dhanir D; Pandrala, Mallesh M; Dheeraj, Arpit A; Li, Wenqi W; Serrano, Ricardo R; Feyen, Dries A M DAM; Vu, Michelle M MM; Amatya, Prashila P; Gupta, Saloni S; Nakauchi, Yusuke Y; Morgado, Isabel I; Wiebking, Volker V; Liao, Ronglih R; Porteus, Matthew H MH; Majeti, Ravindra R; Malhotra, Sanjay V SV; Mercola, Mark M

Publication Date: 2022-08-03

Variant appearance in text: FGFR3: G697C

PubMed Link: 35763671

Variant Present in the following documents:

• can-21-3652_supplementary_table_s1_suppst1.xls, sheet 2

View BVdb publication page

---

Design and biological evaluation of substituted 5,7-dihydro-6H-indolo[2,3-c]quinolin-6-one as novel selective Haspin inhibitors.

Journal Of Enzyme Inhibition And Medicinal Chemistry

Avula, Sreenivas S; Peng, Xudan X; Lang, Xingfen X; Tortorella, Micky M; Josselin, Béatrice B; Bach, Stéphane S; Bourg, Stephane S; Bonnet, Pascal P; Buron, Frédéric F; Ruchaud, Sandrine S; Routier, Sylvain S; Neagoie, Cleopatra C

Publication Date: 2022-12

Variant appearance in text: FGFR3: G697C

PubMed Link: 35670091

Variant Present in the following documents:

• IENZ_A_2082419_SM0502.pdf

View BVdb publication page

---

Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 In Vivo.

Journal Of Medicinal Chemistry

Huckvale, Rosemary R; Harnden, Alice C AC; Cheung, Kwai-Ming J KJ; Pierrat, Olivier A OA; Talbot, Rachel R; Box, Gary M GM; Henley, Alan T AT; de Haven Brandon, Alexis K AK; Hallsworth, Albert E AE; Bright, Michael D MD; Akpinar, Hafize Aysin HA; Miller, Daniel S J DSJ; Tarantino, Dalia D; Gowan, Sharon S; Hayes, Angela A; Gunnell, Emma A EA; Brennan, Alfie A; Davis, Owen A OA; Johnson, Louise D LD; de Klerk, Selby S; McAndrew, Craig C; Le Bihan, Yann-Vaï YV; Meniconi, Mirco M; Burke, Rosemary R; Kirkin, Vladimir V; van Montfort, Rob L M RLM; Raynaud, Florence I FI; Rossanese, Olivia W OW; Bellenie, Benjamin R BR; Hoelder, Swen S

Publication Date: 2022-06-23

Variant appearance in text: FGFR3: G697C

PubMed Link: 35653645

Variant Present in the following documents:

• jm1c02175_si_002.xlsx, sheet 2

View BVdb publication page

---

Pyronaridine Protects against SARS-CoV-2 Infection in Mouse.

Acs Infectious Diseases

Puhl, Ana C AC; Gomes, Giovanni F GF; Damasceno, Samara S; Godoy, Andre S AS; Noske, Gabriela D GD; Nakamura, Aline M AM; Gawriljuk, Victor O VO; Fernandes, Rafaela S RS; Monakhova, Natalia N; Riabova, Olga O; Lane, Thomas R TR; Makarov, Vadim V; Veras, Flavio P FP; Batah, Sabrina S SS; Fabro, Alexandre T AT; Oliva, Glaucius G; Cunha, Fernando Q FQ; Alves-Filho, José C JC; Cunha, Thiago M TM; Ekins, Sean S

Publication Date: 2022-06-10

Variant appearance in text: FGFR3: G697C

PubMed Link: 35609344

Variant Present in the following documents:

• id2c00091_si_001.pdf

View BVdb publication page

---

Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation.

Neoplasia (New York, N.Y.)

Nam, Yunju Y; Shin, Injae I; Kim, Younghoon Y; Ryu, SeongShick S; Kim, Namdoo N; Ju, Eunhye E; Sim, Taebo T

Publication Date: 2022-01

Variant appearance in text: FGFR3: G697C

PubMed Link: 34864570

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

---

Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation.

Neoplasia (New York, N.Y.)

Nam, Yunju Y; Shin, Injae I; Kim, Younghoon Y; Ryu, SeongShick S; Kim, Namdoo N; Ju, Eunhye E; Sim, Taebo T

Publication Date: 2021-12-02

Variant appearance in text: FGFR3: G697C

PubMed Link: 34864570

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

---

Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells.

Cell Death & Disease

Meng, Ya Y; Song, Chengcheng C; Ren, Zhili Z; Li, Xiaohong X; Yang, Xiangyu X; Ai, Nana N; Yang, Yang Y; Wang, Dongjin D; Zhan, Meixiao M; Wang, Jiaxian J; Lei, Chon Lok CL; Liu, Weiwei W; Ge, Wei W; Lu, Ligong L; Chen, Guokai G

Publication Date: 2021-11-29

Variant appearance in text: FGFR3: G697C

PubMed Link: 34845199

Variant Present in the following documents:

• 41419_2021_4395_MOESM9_ESM.xlsx, sheet 1

View BVdb publication page

---

Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology

Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C

Publication Date: 2021

Variant appearance in text: FGFR3: G697C

PubMed Link: 34630336

Variant Present in the following documents:

• Table_1.xlsx, sheet 2

View BVdb publication page

---

Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors.

Journal Of Medicinal Chemistry

Henderson, Scott H SH; Sorrell, Fiona F; Bennett, James J; Fedorov, Oleg O; Hanley, Marcus T MT; Godoi, Paulo H PH; Ruela de Sousa, Roberta R; Robinson, Sean S; Ashall-Kelly, Alexander A; Hopkins Navratilova, Iva I; Walter, Daryl S DS; Elkins, Jonathan M JM; Ward, Simon E SE

Publication Date: 2021-08-12

Variant appearance in text: FGFR3: G697C

PubMed Link: 34342227

Variant Present in the following documents:

• jm1c01115_si_002.xlsx, sheet 8
• jm1c01115_si_002.xlsx, sheet 14
• jm1c01115_si_002.xlsx, sheet 1
• jm1c01115_si_002.xlsx, sheet 3
• jm1c01115_si_002.xlsx, sheet 6
• jm1c01115_si_002.xlsx, sheet 4
• jm1c01115_si_002.xlsx, sheet 13
• jm1c01115_si_002.xlsx, sheet 7
• jm1c01115_si_002.xlsx, sheet 11
• jm1c01115_si_002.xlsx, sheet 10
• jm1c01115_si_002.xlsx, sheet 12
• jm1c01115_si_002.xlsx, sheet 5
• jm1c01115_si_002.xlsx, sheet 2
• jm1c01115_si_002.xlsx, sheet 9

View BVdb publication page

---

Phosphorylated WNK kinase networks in recoded bacteria recapitulate physiological function.

Cell Reports

Schiapparelli, Paula P; Pirman, Natasha L NL; Mohler, Kyle K; Miranda-Herrera, Pierre A PA; Zarco, Natanael N; Kilic, Onur O; Miller, Chad C; Shah, Sagar R SR; Rogulina, Svetlana S; Hungerford, William W; Abriola, Laura L; Hoyer, Denton D; Turk, Benjamin E BE; Guerrero-Cázares, Hugo H; Isaacs, Farren J FJ; Quiñones-Hinojosa, Alfredo A; Levchenko, Andre A; Rinehart, Jesse J

Publication Date: 2021-07-20

Variant appearance in text: FGFR3: G697C

PubMed Link: 34289367

Variant Present in the following documents:

• NIHMS1726840-supplement-2.xlsx, sheet 1

View BVdb publication page

---

Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer.

Npj Precision Oncology

Nakamura, Ikuko Takeda IT; Kohsaka, Shinji S; Ikegami, Masachika M; Ikeuchi, Hiroshi H; Ueno, Toshihide T; Li, Kunhua K; Beyett, Tyler S TS; Koyama, Takafumi T; Shimizu, Toshio T; Yamamoto, Noboru N; Takahashi, Fumiyuki F; Takahashi, Kazuhisa K; Eck, Michael J MJ; Mano, Hiroyuki H

Publication Date: 2021-07-16

Variant appearance in text: FGFR3: G697C

PubMed Link: 34272467

Variant Present in the following documents:

• 41698_2021_Article_204.pdf

View BVdb publication page

---

Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes.

Journal Of Medicinal Chemistry

Eduful, Benjamin J BJ; O'Byrne, Sean N SN; Temme, Louisa L; Asquith, Christopher R M CRM; Liang, Yi Y; Picado, Alfredo A; Pilotte, Joseph R JR; Hossain, Mohammad Anwar MA; Wells, Carrow I CI; Zuercher, William J WJ; Catta-Preta, Carolina M C CMC; Zonzini Ramos, Priscila P; Santiago, André de S AS; Couñago, Rafael M RM; Langendorf, Christopher G CG; Nay, Kévin K; Oakhill, Jonathan S JS; Pulliam, Thomas L TL; Lin, Chenchu C; Awad, Dominik D; Willson, Timothy M TM; Frigo, Daniel E DE; Scott, John W JW; Drewry, David H DH

Publication Date: 2021-08-12

Variant appearance in text: FGFR3: G697C

PubMed Link: 34264658

Variant Present in the following documents:

• jm0c02274_si_003.xlsx, sheet 1

View BVdb publication page

---

GZD824 overcomes FGFR1-V561F/M mutant resistance in vitro and in vivo.

Cancer Medicine

Jiang, Kaili K; Tang, Xia X; Guo, Jing J; He, Rui R; Chan, Shingpan S; Song, Xiaojuan X; Tu, Zhengchao Z; Wang, Yuting Y; Ren, Xiaomei X; Ding, Ke K; Zhang, Zhang Z

Publication Date: 2021-07

Variant appearance in text: FGFR3: G697C

PubMed Link: 34114373

Variant Present in the following documents:

• Main text
• CAM4-10-4874.pdf

View BVdb publication page

---

Evolution of kinase polypharmacology across HSP90 drug discovery.

Cell Chemical Biology

Antolin, Albert A AA; Clarke, Paul A PA; Collins, Ian I; Workman, Paul P; Al-Lazikani, Bissan B

Publication Date: 2021-10-21

Variant appearance in text: FGFR3: G697C

PubMed Link: 34077750

Variant Present in the following documents:

• mmc4.xlsx, sheet 1

View BVdb publication page

---

Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature.

Thoracic Cancer

Asselta, Rosanna R; Di Tommaso, Luca L; Perrino, Matteo M; Destro, Annarita A; Giordano, Laura L; Cardamone, Giulia G; Rubino, Luca L; Santoro, Armando A; Duga, Stefano S; Zucali, Paolo Andrea PA

Publication Date: 2021-05

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 33704917

Variant Present in the following documents:

• TCA-12-1271-s003.xls, sheet 1

View BVdb publication page

---

Usefulness of a novel device to divide core needle biopsy specimens in a spatially matched fashion.

Scientific Reports

Shiraishi, Takumi T; Inui, Shogo S; Inoue, Yuta Y; Saito, Yumiko Y; Taga, Hideto H; Kaneko, Masatomo M; Tsuji, Keisuke K; Ueda, Saya S; Ueda, Takashi T; Matsugasumi, Toru T; Taniguchi, Hidefumi H; Ueno, Akihisa A; Yamada, Takeshi T; Yamada, Yasuhiro Y; Iwata, Tsuyoshi T; Fujihara, Atsuko A; Hongo, Fumiya F; Ukimura, Osamu O

Publication Date: 2020-10-13

Variant appearance in text: rs121913480

PubMed Link: 33051506

Variant Present in the following documents:

• 41598_2020_74136_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma.

Signal Transduction And Targeted Therapy

Liu, Juan J; Liang, Qianmao Q; Wang, Aoli A; Zou, Fengming F; Qi, Ziping Z; Yu, Kailin K; Liu, Qingwang Q; Chen, Cheng C; Liu, Jing J; Liu, Qingsong Q

Publication Date: 2020-09-14

Variant appearance in text: FGFR3: G697C

PubMed Link: 32929063

Variant Present in the following documents:

• 41392_2020_309_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy.

Iscience

Singh, Vibha V; Bhoir, Siddhant S; Chikhale, Rupesh V RV; Hussain, Javeena J; Dwyer, Donard D; Bryce, Richard A RA; Kirubakaran, Sivapriya S; De Benedetti, Arrigo A

Publication Date: 2020-08-20

Variant appearance in text: FGFR3: G697C

PubMed Link: 32905878

Variant Present in the following documents:

• mmc2.xlsx, sheet 1

View BVdb publication page

---

Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells.

Cancers

Cash, Timothy P TP; Alcalá, Sonia S; Rico-Ferreira, María Del Rosario MDR; Hernández-Encinas, Elena E; García, Jennifer J; Albarrán, María Isabel MI; Valle, Sandra S; Muñoz, Javier J; Martínez-González, Sonia S; Blanco-Aparicio, Carmen C; Pastor, Joaquín J; Serrano, Manuel M; Sainz, Bruno B

Publication Date: 2020-07-04

Variant appearance in text: FGFR3: G697C

PubMed Link: 32635473

Variant Present in the following documents:

• cancers-12-01790-s001.pdf

View BVdb publication page

---

Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association

Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H

Publication Date: 2020-07

Variant appearance in text: FGFR3: G697C

PubMed Link: 32107691

Variant Present in the following documents:

• 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12

View BVdb publication page

---

The kinase polypharmacology landscape of clinical PARP inhibitors.

Scientific Reports

Antolin, Albert A AA; Ameratunga, Malaka M; Banerji, Udai U; Clarke, Paul A PA; Workman, Paul P; Al-Lazikani, Bissan B

Publication Date: 2020-02-17

Variant appearance in text: FGFR3: G697C

PubMed Link: 32066817

Variant Present in the following documents:

• 41598_2020_59074_MOESM1_ESM.xlsx, sheet 5

View BVdb publication page

---

Development and validation of a targeted gene sequencing panel for application to disparate cancers.

Scientific Reports

McCabe, Mark J MJ; Gauthier, Marie-Emilie A MA; Chan, Chia-Ling CL; Thompson, Tanya J TJ; De Sousa, Sunita M C SMC; Puttick, Clare C; Grady, John P JP; Gayevskiy, Velimir V; Tao, Jiang J; Ying, Kevin K; Cipponi, Arcadi A; Deng, Niantao N; Swarbrick, Alex A; Thomas, Melissa L ML; Lord, Reginald V RV; Johns, Amber L AL; Kohonen-Corish, Maija M; O'Toole, Sandra A SA; Clark, Jonathan J; Mueller, Simon A SA; Gupta, Ruta R; McCormack, Ann I AI; Dinger, Marcel E ME; Cowley, Mark J MJ; ,

Publication Date: 2019-11-19

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 31745186

Variant Present in the following documents:

• 41598_2019_52000_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Validation and Clinical Applications of a Comprehensive Next Generation Sequencing System for Molecular Characterization of Solid Cancer Tissues.

Frontiers In Molecular Biosciences

Dehghani, Mehdi M; Rosenblatt, Kevin P KP; Li, Lei L; Rakhade, Mrudula M; Amato, Robert J RJ

Publication Date: 2019

Variant appearance in text: FGFR3: Gly697Cys

PubMed Link: 31681791

Variant Present in the following documents:

• Data_Sheet_5.pdf

View BVdb publication page

---

Identification of New Mono/Dihydroxynaphthoquinone as Lead Agents That Inhibit the Growth of Refractive and Triple-Negative Breast Cancer Cell Lines.

Acs Omega

Schroeder, Richard R; Sfondouris, Mary M; Goyal, Navneet N; Komati, Rajesh R; Weerathunga, Achira A; Gettridge, Cory C; Stevens, Cheryl L Klein CLK; Jones, Frank E FE; Sridhar, Jayalakshmi J

Publication Date: 2019-06-30

Variant appearance in text: FGFR3: G697C

PubMed Link: 31460159

Variant Present in the following documents:

• ao9b00929_si_001.pdf

View BVdb publication page

---

Fibroblast Growth Factor Receptor Signaling in Skin Cancers.

Cells

Czyz, Malgorzata M

Publication Date: 2019-06-04

Variant appearance in text: FGFR3: Gly697Cys

PubMed Link: 31167513

Variant Present in the following documents:

• Main text
• cells-08-00540.pdf

View BVdb publication page

---

RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases.

Cell Death And Differentiation

Patel, Snahel S; Webster, Joshua D JD; Varfolomeev, Eugene E; Kwon, Youngsu C YC; Cheng, Jason H JH; Zhang, Juan J; Dugger, Debra L DL; Wickliffe, Kate E KE; Maltzman, Allie A; Sujatha-Bhaskar, Swathi S; Bir Kohli, Pawan P; Ramaswamy, Sreema S; Deshmukh, Gauri G; Liederer, Bianca M BM; Fong, Rina R; Hamilton, Greg G; Lupardus, Patrick P; Caplazi, Patrick P; Lee, Wyne P WP; van Lookeren Campagne, Menno M; Johnson, Adam A; McKenzie, Brent S BS; Junttila, Melissa R MR; Newton, Kim K; Vucic, Domagoj D

Publication Date: 2020-01

Variant appearance in text: FGFR3: G697C

PubMed Link: 31101885

Variant Present in the following documents:

• 41418_2019_347_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.

Mbio

Caro-Vegas, Carolina C; Bailey, Aubrey A; Bigi, Rachele R; Damania, Blossom B; Dittmer, Dirk P DP

Publication Date: 2019-02-19

Variant appearance in text: FGFR3: G697C

PubMed Link: 30782662

Variant Present in the following documents:

• mBio.02871-18-st001.xlsx, sheet 1

View BVdb publication page

---

Targeted mutation detection in breast cancer using MammaSeq™.

Breast Cancer Research : Bcr

Smith, Nicholas G NG; Gyanchandani, Rekha R; Shah, Osama S OS; Gurda, Grzegorz T GT; Lucas, Peter C PC; Hartmaier, Ryan J RJ; Brufsky, Adam M AM; Puhalla, Shannon S; Bahreini, Amir A; Kota, Karthik K; Wald, Abigail I AI; Nikiforov, Yuri E YE; Nikiforova, Marina N MN; Oesterreich, Steffi S; Lee, Adrian V AV

Publication Date: 2019-02-08

Variant appearance in text: FGFR3: G697C

PubMed Link: 30736836

Variant Present in the following documents:

• 13058_2019_1102_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting.

Biochemical Society Transactions

Farrell, Brendan B; Breeze, Alexander L AL

Publication Date: 2018-12-17

Variant appearance in text: FGFR3: G697C

PubMed Link: 30545934

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Inhibition of CPAP-tubulin interaction prevents proliferation of centrosome-amplified cancer cells.

The Embo Journal

Mariappan, Aruljothi A; Soni, Komal K; Schorpp, Kenji K; Zhao, Fan F; Minakar, Amin A; Zheng, Xiangdong X; Mandad, Sunit S; Macheleidt, Iris I; Ramani, Anand A; Kubelka, Tomáš T; Dawidowski, Maciej M; Golfmann, Kristina K; Wason, Arpit A; Yang, Chunhua C; Simons, Judith J; Schmalz, Hans-Günther HG; Hyman, Anthony A AA; Aneja, Ritu R; Ullrich, Roland R; Urlaub, Henning H; Odenthal, Margarete M; Büttner, Reinhardt R; Li, Haitao H; Sattler, Michael M; Hadian, Kamyar K; Gopalakrishnan, Jay J

Publication Date: 2019-01-15

Variant appearance in text: FGFR3: G697C

PubMed Link: 30530478

Variant Present in the following documents:

• EMBJ-38-e99876-s004.xlsx, sheet 1

View BVdb publication page

---

The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models.

Oncotarget

Kim, Sunkyu S; Tiedt, Ralph R; Loo, Alice A; Horn, Thomas T; Delach, Scott S; Kovats, Steven S; Haas, Kristy K; Engstler, Barbara Schacher BS; Cao, Alexander A; Pinzon-Ortiz, Maria M; Mulford, Iain I; Acker, Michael G MG; Chopra, Rajiv R; Brain, Christopher C; di Tomaso, Emmanuelle E; Sellers, William R WR; Caponigro, Giordano G

Publication Date: 2018-10-16

Variant appearance in text: FGFR3: G697C

PubMed Link: 30443290

Variant Present in the following documents:

• oncotarget-09-35226-s002.xlsx, sheet 1

View BVdb publication page

---

Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia.

Cancers

Musumeci, Francesca F; Greco, Chiara C; Grossi, Giancarlo G; Molinari, Alessio A; Schenone, Silvia S

Publication Date: 2018-11-09

Variant appearance in text: FGFR3: G697C

PubMed Link: 30423915

Variant Present in the following documents:

• cancers-10-00430.pdf

View BVdb publication page

---

Validation of the Oncomine™ focus panel for next-generation sequencing of clinical tumour samples.

Virchows Archiv : An International Journal Of Pathology

Williams, Hannah L HL; Walsh, Kathy K; Diamond, Austin A; Oniscu, Anca A; Deans, Zandra C ZC

Publication Date: 2018-10

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 30105577

Variant Present in the following documents:

• 428_2018_2411_MOESM1_ESM.xlsx, sheet 3
• 428_2018_2411_MOESM1_ESM.xlsx, sheet 4
• 428_2018_2411_MOESM1_ESM.xlsx, sheet 1
• 428_2018_2411_MOESM4_ESM.xlsx, sheet 1
• 428_2018_2411_MOESM3_ESM.xlsx, sheet 1
• 428_2018_2411_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma.

Bmc Urology

Kim, Young Saing YS; Kim, Kyung K; Kwon, Ghee-Young GY; Lee, Su Jin SJ; Park, Se Hoon SH

Publication Date: 2018-07-31

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 30064409

Variant Present in the following documents:

• 12894_2018_380_MOESM1_ESM.xlsx, sheet 1

View BVdb publication page

---

Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study.

Japanese Journal Of Clinical Oncology

Naito, Yoichi Y; Takahashi, Hideaki H; Shitara, Kohei K; Okamoto, Wataru W; Bando, Hideaki H; Kuwata, Takeshi T; Kuboki, Yasutoshi Y; Matsumoto, Shingo S; Miki, Izumi I; Yamanaka, Takeharu T; Watanabe, Atsushi A; Kojima, Motohiro M

Publication Date: 2018-06-01

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 29659903

Variant Present in the following documents:

• hyy052supplementaltable1ionver1.xls, sheet 1

View BVdb publication page

---

CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells.

Oncotarget

Nakamura, Akito A; Nakata, Daisuke D; Kakoi, Yuichi Y; Kunitomo, Mihoko M; Murai, Saomi S; Ebara, Shunsuke S; Hata, Akito A; Hara, Takahito T

Publication Date: 2018-03-02

Variant appearance in text: FGFR3: G697C

PubMed Link: 29568371

Variant Present in the following documents:

• oncotarget-09-13474-s003.xlsx, sheet 1
• oncotarget-09-13474-s002.xlsx, sheet 1

View BVdb publication page

---

Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System.

Structure (London, England : 1993)

Bunney, Tom D TD; Inglis, Alison J AJ; Sanfelice, Domenico D; Farrell, Brendan B; Kerr, Christopher J CJ; Thompson, Gary S GS; Masson, Glenn R GR; Thiyagarajan, Nethaji N; Svergun, Dmitri I DI; Williams, Roger L RL; Breeze, Alexander L AL; Katan, Matilda M

Publication Date: 2018-03-06

Variant appearance in text: FGFR3: G697C

PubMed Link: 29478821

Variant Present in the following documents:

• mmc3.pdf
• mmc1.pdf

View BVdb publication page

---

Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs).

Oncotarget

Yu, Kailin K; Liu, Xuesong X; Jiang, Zongru Z; Hu, Chen C; Zou, Fengming F; Chen, Cheng C; Ge, Juan J; Wu, Jiaxin J; Liu, Xiaochuan X; Wang, Aoli A; Wang, Wenliang W; Wang, Wenchao W; Qi, Ziping Z; Wang, Beilei B; Wang, Li L; Yan, Hezhong H; Wang, Jiaoxue J; Ren, Tao T; Tang, Jun J; Liu, Qingsong Q; Liu, Jing J

Publication Date: 2017-12-19

Variant appearance in text: FGFR3: G697C

PubMed Link: 29340041

Variant Present in the following documents:

• oncotarget-08-111110-s002.xlsx, sheet 1

View BVdb publication page

---

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract.

Translational Oncology

Lee, Ji Yun JY; Kim, Kyung K; Sung, Hyun Hwan HH; Jeon, Hwang Gyun HG; Jeong, Byong Chang BC; Seo, Seong Il SI; Jeon, Seong Soo SS; Lee, Hyun Moo HM; Choi, Han-Yong HY; Kwon, Ghee-Young GY; Kim, Kyoung-Mee KM; Lee, Jeeyun J; Lim, Ho Yeong HY; Park, Se Hoon SH

Publication Date: 2018-02

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 29161613

Variant Present in the following documents:

• mmc1.xlsx, sheet 1

View BVdb publication page

---

Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity.

Oncotarget

Dohmen, Amy J C AJC; Qiao, Xiaohang X; Duursma, Anja A; Wijdeven, Ruud H RH; Lieftink, Cor C; Hageman, Floor F; Morris, Ben B; Halonen, Pasi P; Vens, Conchita C; van den Brekel, Michiel W M MWM; Ovaa, Huib H; Neefjes, Jacques J; Zuur, Charlotte L CL

Publication Date: 2017-09-26

Variant appearance in text: FGFR3: G697C

PubMed Link: 29088757

Variant Present in the following documents:

• oncotarget-08-73925-s002.xlsx, sheet 1

View BVdb publication page

---

Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of Akt.

Scientific Reports

Huang, Bill X BX; Newcomer, Kenny K; Kevala, Karl K; Barnaeva, Elena E; Zheng, Wei W; Hu, Xin X; Patnaik, Samarjit S; Southall, Noel N; Marugan, Juan J; Ferrer, Marc M; Kim, Hee-Yong HY

Publication Date: 2017-09-15

Variant appearance in text: FGFR3: G697C

PubMed Link: 28916818

Variant Present in the following documents:

• 41598_2017_11870_MOESM1_ESM.pdf

View BVdb publication page

---

A UV-Independent Topical Small-Molecule Approach for Melanin Production in Human Skin.

Cell Reports

Mujahid, Nisma N; Liang, Yanke Y; Murakami, Ryo R; Choi, Hwan Geun HG; Dobry, Allison S AS; Wang, Jinhua J; Suita, Yusuke Y; Weng, Qing Yu QY; Allouche, Jennifer J; Kemeny, Lajos V LV; Hermann, Andrea L AL; Roider, Elisabeth M EM; Gray, Nathanael S NS; Fisher, David E DE

Publication Date: 2017-06-13

Variant appearance in text: FGFR3: G697C

PubMed Link: 28614705

Variant Present in the following documents:

• NIHMS882886-supplement-2.xlsx, sheet 1

View BVdb publication page

---

Biological characterization of SN32976, a selective inhibitor of PI3K and mTOR with preferential activity to PI3Kα, in comparison to established pan PI3K inhibitors.

Oncotarget

Rewcastle, Gordon W GW; Kolekar, Sharada S; Buchanan, Christina M CM; Gamage, Swarna A SA; Giddens, Anna C AC; Tsang, Kit Y KY; Kendall, Jackie D JD; Singh, Ripudaman R; Lee, Woo-Jeong WJ; Smith, Greg C GC; Han, Weiping W; Matthews, David J DJ; Denny, William A WA; Shepherd, Peter R PR; Jamieson, Stephen M F SMF

Publication Date: 2017-07-18

Variant appearance in text: FGFR3: G697C

PubMed Link: 28537878

Variant Present in the following documents:

• oncotarget-08-47725-s002.xlsx, sheet 1

View BVdb publication page

---

Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode.

Oncotarget

Hu, Chen C; Wang, Aoli A; Wu, Hong H; Qi, Ziping Z; Li, Xixiang X; Yan, Xiao-E XE; Chen, Cheng C; Yu, Kailin K; Zou, Fengming F; Wang, Wenchao W; Wang, Wei W; Wu, Jiaxin J; Liu, Juan J; Wang, Beilei B; Wang, Li L; Ren, Tao T; Zhang, Shanchun S; Yun, Cai-Hong CH; Liu, Jing J; Liu, Qingsong Q

Publication Date: 2017-03-14

Variant appearance in text: FGFR3: G697C

PubMed Link: 28407693

Variant Present in the following documents:

View BVdb publication page

---

Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations.

Genome Research

Brammeld, Jonathan S JS; Petljak, Mia M; Martincorena, Inigo I; Williams, Steven P SP; Alonso, Luz Garcia LG; Dalmases, Alba A; Bellosillo, Beatriz B; Robles-Espinoza, Carla Daniela CD; Price, Stacey S; Barthorpe, Syd S; Tarpey, Patrick P; Alifrangis, Constantine C; Bignell, Graham G; Vidal, Joana J; Young, Jamie J; Stebbings, Lucy L; Beal, Kathryn K; Stratton, Michael R MR; Saez-Rodriguez, Julio J; Garnett, Mathew M; Montagut, Clara C; Iorio, Francesco F; McDermott, Ultan U

Publication Date: 2017-04

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 28179366

Variant Present in the following documents:

• supp_gr.213546.116_Supplemental_Table_S7.xlsx, sheet 1

View BVdb publication page

---

Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins.

Antiviral Research

Beelontally, Rooksarr R; Wilkie, Gavin S GS; Lau, Betty B; Goodmaker, Charles J CJ; Ho, Catherine M K CMK; Swanson, Chad M CM; Deng, Xianming X; Wang, Jinhua J; Gray, Nathanael S NS; Davison, Andrew J AJ; Strang, Blair L BL

Publication Date: 2017-02

Variant appearance in text: FGFR3: G697C

PubMed Link: 27956134

Variant Present in the following documents:

• mmc2.xlsx, sheet 4
• mmc2.xlsx, sheet 6
• mmc2.xlsx, sheet 5

View BVdb publication page

---

Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples.

Plos One

Kurobe, Masahiro M; Kojima, Takahiro T; Nishimura, Kouichi K; Kandori, Shuya S; Kawahara, Takashi T; Yoshino, Takayuki T; Ueno, Satoshi S; Iizumi, Yuichi Y; Mitsuzuka, Koji K; Arai, Yoichi Y; Tsuruta, Hiroshi H; Habuchi, Tomonori T; Kobayashi, Takashi T; Matsui, Yoshiyuki Y; Ogawa, Osamu O; Sugimoto, Mikio M; Kakehi, Yoshiyuki Y; Nagumo, Yoshiyuki Y; Tsutsumi, Masakazu M; Oikawa, Takehiro T; Kikuchi, Koji K; Nishiyama, Hiroyuki H

Publication Date: 2016

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 27930669

Variant Present in the following documents:

• pone.0165109.s007.xlsx, sheet 1

View BVdb publication page

---

Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?

Journal Of Chemical Information And Modeling

Christmann-Franck, Serge S; van Westen, Gerard J P GJ; Papadatos, George G; Beltran Escudie, Fanny F; Roberts, Alexander A; Overington, John P JP; Domine, Daniel D

Publication Date: 2016-09-26

Variant appearance in text: FGFR3: G697C

PubMed Link: 27482722

Variant Present in the following documents:

• ci6b00122_si_004.xlsx, sheet 4

View BVdb publication page

---

Roles of FGFR in oral carcinogenesis.

Cell Proliferation

Xie, Xiaoyan X; Wang, Zhiyong Z; Chen, Fangman F; Yuan, Yao Y; Wang, Jiayi J; Liu, Rui R; Chen, Qianming Q

Publication Date: 2016-06

Variant appearance in text: FGFR3: G697C

PubMed Link: 27218663

Variant Present in the following documents:

• Main text

View BVdb publication page

---

A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors.

Scientific Reports

Wei, Yuming Y; Poon, Daniel C DC; Fei, Rong R; Lam, Amy S M AS; Au-Yeung, Steve C F SC; To, Kenneth K W KK

Publication Date: 2016-05-06

Variant appearance in text: FGFR3: G697C

PubMed Link: 27150583

Variant Present in the following documents:

• srep25363-s1.pdf

View BVdb publication page

---

Establishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform.

Cancer Biology & Medicine

Tian, Hong-Xia HX; Zhang, Xu-Chao XC; Wang, Zhen Z; Chen, Jian-Guang JG; Chen, Shi-Liang SL; Guo, Wei-Bang WB; Wu, Yi-Long YL

Publication Date: 2016-03

Variant appearance in text: FGFR3: G697C

PubMed Link: 27144063

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Characterization of selective and potent PI3Kδ inhibitor (PI3KDIN- 015) for B-Cell malignances.

Oncotarget

Liu, Xiaochuan X; Wang, Aoli A; Liang, Xiaofei X; Chen, Cheng C; Liu, Juanjuan J; Zhao, Zheng Z; Wu, Hong H; Deng, Yuanxin Y; Wang, Li L; Wang, Beilei B; Wu, Jiaxin J; Liu, Feiyang F; Fernandes, Stacey M SM; Adamia, Sophia S; Stone, Richard M RM; Galinsky, Ilene A IA; Brown, Jennifer R JR; Griffin, James D JD; Zhang, Shanchun S; Loh, Teckpeng T; Zhang, Xin X; Wang, Wenchao W; Weisberg, Ellen L EL; Liu, Jing J; Liu, Qingsong Q

Publication Date: 2016-05-31

Variant appearance in text: FGFR3: G697C

PubMed Link: 27081697

Variant Present in the following documents:

• oncotarget-07-32641-s002.xlsx, sheet 1

View BVdb publication page

---

Integrated digital error suppression for improved detection of circulating tumor DNA.

Nature Biotechnology

Newman, Aaron M AM; Lovejoy, Alexander F AF; Klass, Daniel M DM; Kurtz, David M DM; Chabon, Jacob J JJ; Scherer, Florian F; Stehr, Henning H; Liu, Chih Long CL; Bratman, Scott V SV; Say, Carmen C; Zhou, Li L; Carter, Justin N JN; West, Robert B RB; Sledge, George W GW; Shrager, Joseph B JB; Loo, Billy W BW; Neal, Joel W JW; Wakelee, Heather A HA; Diehn, Maximilian M; Alizadeh, Ash A AA

Publication Date: 2016-05

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 27018799

Variant Present in the following documents:

• NIHMS764326-supplement-6.xlsx, sheet 1

View BVdb publication page

---

Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use.

Oncotarget

Patani, Harshnira H; Bunney, Tom D TD; Thiyagarajan, Nethaji N; Norman, Richard A RA; Ogg, Derek D; Breed, Jason J; Ashford, Paul P; Potterton, Andrew A; Edwards, Mina M; Williams, Sarah V SV; Thomson, Gary S GS; Pang, Camilla S M CS; Knowles, Margaret A MA; Breeze, Alexander L AL; Orengo, Christine C; Phillips, Chris C; Katan, Matilda M

Publication Date: 2016-04-26

Variant appearance in text: FGFR3: G697C

PubMed Link: 26992226

Variant Present in the following documents:

• Main text
• oncotarget-07-24252-s001.pdf
• oncotarget-07-24252.pdf

View BVdb publication page

---

Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations.

Cancer Biology & Therapy

Kim, Do-Hee DH; Kwak, Yeonui Y; Kim, Nam Doo ND; Sim, Taebo T

Publication Date: 2016

Variant appearance in text: FGFR3: G697C

PubMed Link: 26574622

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.

Oncotarget

Lee, Ji Yun JY; Park, Kyunghee K; Lim, Sung Hee SH; Kim, Hae Su HS; Yoo, Kwai Han KH; Jung, Ki Sun KS; Song, Haa-Na HN; Hong, Mineui M; Do, In-Gu IG; Ahn, TaeJin T; Lee, Se Kyung SK; Bae, Soo Youn SY; Kim, Seok Won SW; Lee, Jeong Eon JE; Nam, Seok Jin SJ; Kim, Duk-Hwan DH; Jung, Hae Hyun HH; Kim, Ji-Yeon JY; Ahn, Jin Seok JS; Im, Young-Hyuck YH; Park, Yeon Hee YH

Publication Date: 2015-12-22

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 26527317

Variant Present in the following documents:

• oncotarget-06-43731-s002.xlsx, sheet 1

View BVdb publication page

---

Patient-derived cell models as preclinical tools for genome-directed targeted therapy.

Oncotarget

Lee, Ji Yun JY; Kim, Sun Young SY; Park, Charny C; Kim, Nayoung K D NK; Jang, Jiryeon J; Park, Kyunghee K; Yi, Jun Ho JH; Hong, Mineui M; Ahn, Taejin T; Rath, Oliver O; Schueler, Julia J; Kim, Seung Tae ST; Do, In-Gu IG; Lee, Sujin S; Park, Se Hoon SH; Ji, Yong Ick YI; Kim, Dukwhan D; Park, Joon Oh JO; Park, Young Suk YS; Kang, Won Ki WK; Kim, Kyoung-Mee KM; Park, Woong-Yang WY; Lim, Ho Yeong HY; Lee, Jeeyun J

Publication Date: 2015-09-22

Variant appearance in text: FGFR3: 2089G>T; G697C

PubMed Link: 26296973

Variant Present in the following documents:

• oncotarget-06-25619-s003.xls, sheet 1

View BVdb publication page

---